S'abonner

Utility of ED triage tools in predicting the need for intensive respiratory or vasopressor support in adult patients with COVID-19 - 19/03/24

Doi : 10.1016/j.ajem.2024.01.034 
Anandhi Deva, MD a, Ronit Juthani, MBBS b, , Ezhil Kugan, MD a, N. Balamurugan, MD a, Manu Ayyan, MD a
a Department of Emergency Medicine & Trauma, JIPMER, Puducherry, India 
b Department of Medicine, Saint Vincent Hospital, Worcester, MA, United States 

Corresponding author at: 26 Portland Street, #208, Worcester, MA 01608, United States.26 Portland Street, #208WorcesterMA01608United States

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

Serum and radiological parameters used to predict prognosis in COVID patients are not feasible in the Emergency Department. Due to its damaging effect on multiple organs and lungs, scores used to assess multiorgan damage and pneumonia such as Pandemic Medical Early Warning Score (PMEWS), National Early Warning Score 2 (NEWS2), WHO score, quick Sequential Organ Failure Assessment (qSOFA), and DS-CRB 65 can be used to triage patients in the Emergency Department. They can be used to predict patients with the highest risk of seven-day mortality and need for intensive respiratory or vasopressor support (IRVS).

Purpose

The primary purpose was to find the score with the highest AUC in predicting IRVS and mortality at seven days. Additional objective was to find out any independent factors associated with IRVS and mortality.

Methods

The data of adult patients who presented to the Emergency Department (ED) between April 1, 2021 and June 30, 2021 were collected. The WHO score, CRB-65, DS-CRB 65, PMEWS, NEWS2, and qSOFA score were calculated for all patients. Statistical analysis was done and an ROC curve was calculated for all the tools for mortality and need for IRVS at seven days.

Findings

677 patients presented to the Emergency Department with COVID-19 during the period above. Presence of Diabetes Mellitus (p = 0.001), Hypertension (p = 0.001), and chronic kidney disease(CKD) (p = 0.04) was significantly associated with need for IRVS. Age, duration of symptoms, pulse rate, respiratory rate, room air saturation, mental status at admission, and time to IRVS need were identified as independent predictors of in-hospital mortality. The longer the time to IRVS need from ED arrival, the higher the likelihood of mortality. PMEWS (0.830) had the highest AUC, followed by NEWS2 (0.805). A PMEWS cut-off of 6.5 was 74.2% sensitive and 78.3% specific in predicting the need for IRVS. ROC analysis to predict 7-day mortality showed that PMEWS had an AUC of 0.802 (0.766–0.839). QSOFA performed poorly in predicting IRVS (AUC 0.645) and 7-day mortality (AUC 0.677).

Conclusion

PMEWS may be used for triaging patients presenting to the Emergency Department with COVID-19 and accurately predicts the need for IRVS and seven day mortality.

Le texte complet de cet article est disponible en PDF.

Highlights

PMEWS has good sensitivity and specificity for predicting the need for intensive respiratory and vasopressor as well as mortality in the next seven days for COVID-19.
Other tools which can be used and that offer comparable ratios include NEWS2, DS-CRB 65, and WHO score.
The mortality increases with the increase in the number of days post admission before ventilator use.
The predictivity of triaging tools can vary not only with the population tested but also with the variant of COVID-19.

Le texte complet de cet article est disponible en PDF.

Keywords : Triage, COVID, MEWS, NEWS, Ventilation


Plan


© 2024  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 78

P. 151-156 - avril 2024 Retour au numéro
Article précédent Article précédent
  • Predictors of cardiac arrest in severe accidental hypothermia
  • Paweł Podsiadło, Tomáš Brožek, Martin Balik, Ewelina Nowak, Konrad Mendrala, Hubert Hymczak, Wojciech Dąbrowski, Bartosz Miazgowski, Aleksander Rutkiewicz, Marian Burysz, Anna Witt-Majchrzak, Tomasz Jędrzejczak, Rafał Podsiadło, Tomasz Darocha, Hypothermia Study Group, Kacper Reszka, Guillaume Debaty, Nicolas Segond, Michał Dudek, Radosław Litwinowicz, Stanisław Górski, Sylweriusz Kosiński, Roch Pakuła
| Article suivant Article suivant
  • Combined modified Valsalva maneuver with adenosine supraventricular tachycardia: A comparative study
  • Lifeng Xiao, Xiaomin Ou, Wanshang Liu, Xiaorong Lin, Lin Peng, Shuyi Qiu, Qishuo Zhang

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.